货号:A121482
同义名:
Programmed Cell Death 1/Programmed Cell Death-Ligand 1 Inhibitor 1; PD-1/PD-L1 inhibitor 1
PD-1/PD-L1 inhibitor 1 is a small-molecule inhibitor of PD-1/PD-L1 interaction with IC50 of 6 nM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | PD-1 ↓ ↑ | PD-1/PD-L1 ↓ ↑ | PD-1/PD-L1 interaction ↓ ↑ | PD-L1 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SR0987 | ✔ | 99% | |||||||||||||||||
Pembrolizumab | ✔ | 98% | |||||||||||||||||
Camrelizumab | ✔ | 5mg/mL | |||||||||||||||||
Spartalizumab | ✔ | 95% | |||||||||||||||||
BMS-1001 |
+
PD-1/PD-L1, EC50: 253 nM |
+
PD-1/PD-L1, EC50: 253 nM |
98% | ||||||||||||||||
INCB086550 |
++
PD-1/PD-L1, IC50: <10 nM |
++
PD-1/PD-L1, IC50: <10 nM |
98% | ||||||||||||||||
BMS-1 |
++
PD-1/PD-L1 interaction, IC50: 0.006 μM |
99%+ | |||||||||||||||||
BMS-202 |
+
PD-1/PD-L1 interaction, IC50: 0.018 μM |
99%+ | |||||||||||||||||
PD-1/PD-L1-IN 3 |
+++
PD-1/PD-L1 interaction, IC50: 5.6 nM |
98+% | |||||||||||||||||
Nivolumab |
+++
PD-1/PD-L1 interaction, IC50: 2.52 nM |
95% | |||||||||||||||||
BMS-1166 |
+++
PD-1/PD-L1 interaction, IC50: 1.4 nM |
99%+ | |||||||||||||||||
Durvalumab |
++++
PD-1/PD-L1 interaction, IC50: 0.1 nM |
95% | |||||||||||||||||
Evixapodlin |
++++
PD-1/PD-L1, IC50: 0.213 nM |
95% | |||||||||||||||||
CA-170 | ✔ | 97% (contains 2.7% ethanol) | |||||||||||||||||
Atezolizumab |
+++
hPD-L1, Kd: 0.4 nM |
99% | |||||||||||||||||
AUNP-12 | ✔ | 99% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | BMS-1 is a selective inhibitor targeting the interaction between PD-1 and PD-L1, with an inhibitory concentration range (IC50) spanning from 6 to 100 nM[1].[2]. |
Animal study | BMS-1 (500 μg/mL; 100 μL; i.p.) markedly enhances the survival rates of the mVEGF165b group and mVEGF165b + MUC1 group[3]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.10mL 0.42mL 0.21mL |
10.51mL 2.10mL 1.05mL |
21.03mL 4.21mL 2.10mL |
CAS号 | 1675201-83-8 |
分子式 | C29H33NO5 |
分子量 | 475.58 |
SMILES Code | O=C([C@H]1N(CC2=C(OC)C=C(OCC3=C(C)C(C4=CC=CC=C4)=CC=C3)C=C2OC)CCCC1)O |
MDL No. | MFCD28978741 |
别名 | Programmed Cell Death 1/Programmed Cell Death-Ligand 1 Inhibitor 1; PD-1/PD-L1 inhibitor 1; PD1-PDL1-IN1; PD1-PDL1 inhibitor 1 |
运输 | 蓝冰 |
InChI Key | ZBOYJODMIAUJHH-SANMLTNESA-N |
Pubchem ID | 91663303 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
动物实验配方 |
IP 5% DMSO + water 0.1 mg/mL clear |